Next Quarterly Earnings
Tuesday, November 17, 2026
CW 47
Pre-Market
In 82 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Bicara Therapeutics
Bicara Therapeutics is a US-based biotechnology company specializing in the development of novel bispecific antibodies for oncology. The company researches innovative cancer therapies designed to modulate the tumor microenvironment and enhance the immune response to provide effective clinical treatments.
Frequently asked questions
When will Bicara Therapeutics report its next quarterly earnings?
Bicara Therapeutics is scheduled to report its next quarterly earnings on 11/17/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Bicara Therapeutics last report quarterly earnings?
Bicara Therapeutics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.82 USD.
How often has Bicara Therapeutics beaten expectations?
Bicara Therapeutics has beaten analyst EPS estimates in 1 of its last 6 evaluated quarters (beat rate: 16.7%).
How do I add the Bicara Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
1/6
Quarters above estimates
16.7%
Beat rate
-7.4%
Avg. EPS surprise
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Bicara Therapeutics
Country
🇺🇸
More Financial Information